Atlas Trials

A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia

Clinical trial NCT02553187 · UNKNOWN

Trial details

NCT number
NCT02553187
Sponsor
Zhejiang Kanglaite Pharmaceutical Co.Ltd
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Cancer Cachexia
Start date
2015-09-01
Primary completion
2017-07-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.